Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Am J Gastroenterol
    February 2026
  1. OCHOA-ALLEMANT P, Kiran A, Mezzacappa C, Kaplan DE, et al
    Steatotic Liver Disease Has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the U.S. Veterans Health System.
    Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003966.
    >> Share

  2. TAPPER EB, Woodrell CD, Rakoski M, Huang R, et al
    Hepatic Encephalopathy is the Key Driver of Symptom Burden in a Longitudinal Cohort of Patients with Advanced Chronic Liver Disease: PAL-LIVER sub-study.
    Am J Gastroenterol. 2026 Feb 13. doi: 10.14309/ajg.0000000000003964.
    >> Share

  3. PATEL N, Silvey S, Bajaj JS
    Vonoprazan Is Associated with Better Liver-Related Outcomes Compared to Proton Pump Inhibitors In Cirrhosis.
    Am J Gastroenterol. 2026 Feb 10. doi: 10.14309/ajg.0000000000003945.
    >> Share

  4. CAVIGLIA GP, Ferro A, D'Ambrosio R, Perbellini R, et al
    Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study.
    Am J Gastroenterol. 2026;121:375-382.
    >> Share

  5. ALKHOURI N, Cheuk-Fung Yip T, Castera L, Takawy M, et al
    ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2026;121:362-374.
    >> Share

    January 2026
  6. SHABBIR R, Garrido-Trevino L, O'Leary JG, Chaudhary A, et al
    MELD-Lactate and lactate clearance in critically ill cirrhosis patients with sepsis.
    Am J Gastroenterol. 2026 Jan 27. doi: 10.14309/ajg.0000000000003934.
    >> Share

  7. JARRAH M, Rich NE, Figueroa G, Garces SM, et al
    Treatment Delays and Survival in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Am J Gastroenterol. 2026 Jan 21. doi: 10.14309/ajg.0000000000003923.
    >> Share

  8. XUE J, Zhang L, Xie N, Lei L, et al
    Primary hepatic somatostatinoma (G2) with diabetes and nodal metastasis: An exceptionally rare primary liver tumor.
    Am J Gastroenterol. 2026 Jan 9. doi: 10.14309/ajg.0000000000003908.
    >> Share

  9. SHROFF H, Shankar A, Baron A, Yoxheimer L, et al
    A Large Language Model Assistant for Summarizing Hepatology Referral Documents.
    Am J Gastroenterol. 2026 Jan 8. doi: 10.14309/ajg.0000000000003905.
    >> Share

  10. AHMAD J, Dellinger A, Nicoletti P, Barnhart HX, et al
    Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network.
    Am J Gastroenterol. 2026;121:151-158.
    >> Share

  11. LE P, Tatar M, Rothberg MB, Wilson LA, et al
    Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2026;121:159-170.
    >> Share

    December 2025
  12. SHROFF H, Fix OK
    Practical Applications of Artificial Intelligence to Improve Efficiency and Reduce Burnout in Gastroenterology and Hepatology Practices.
    Am J Gastroenterol. 2025 Dec 16. doi: 10.14309/ajg.0000000000003887.
    >> Share

  13. CHOI J, Nguyen VH, Przybyszewski E, Song J, et al
    Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes.
    Am J Gastroenterol. 2025 Dec 16. doi: 10.14309/ajg.0000000000003889.
    >> Share

  14. ABU-RUMAILEH M, Dhoop S, Pace J, Qapaja T, et al
    Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2025;120:2810-2820.
    >> Share

    November 2025
  15. RODRIGUEZ N, Katzenstein C, Alpert L, Sigel K, et al
    Evaluating the 2023 EASL guidelines for intrahepatic cholestasis of pregnancy: risk stratification and outcomes in over 4,000 U.S. patients.
    Am J Gastroenterol. 2025 Nov 24. doi: 10.14309/ajg.0000000000003866.
    >> Share

  16. PATIDAR KR, Hall L, Ogola GO, Pike F, et al
    Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003854.
    >> Share

  17. SWAIN LA, Godley J, Wang M, Brahmania M, et al
    Temporal and demographic trends in alcohol-related-cirrhosis, alcohol-related hepatitis, and non-alcohol-related cirrhosis hospitalizations from 2012-2023: A population-based study in Alberta, Canada.
    Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003835.
    >> Share

  18. SMITH L, Sciacca K, Durieux BN, Bizup G, et al
    Harnessing Natural Language Processing to Identify Documentation of Serious Illness Communication for Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003830.
    >> Share

  19. SILVEY S, Patel N, Davis BC, Sterling RK, et al
    Use of Natural language processing to objectively identify hepatic encephalopathy in multiple cohorts.
    Am J Gastroenterol. 2025 Nov 6. doi: 10.14309/ajg.0000000000003824.
    >> Share

  20. BURTON R, Leggio L, Louvet A, Sheron N, et al
    Prevention of Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2025;120:2487-2501.
    >> Share

  21. JOHN BV, Bastaich D, Mezzacappa C, Ferreira RD, et al
    Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease Using Natural Language Processing in a US National Cohort.
    Am J Gastroenterol. 2025;120:2583-2591.
    >> Share

  22. SHENOY A, Jasty VS, Uttal S, Nasser S, et al
    Medications for Alcohol Use Disorder Are Increasingly Being Prescribed in American Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2025;120:2576-2582.
    >> Share

  23. NIEZEN S, Morgan TR, Scott D, Yakovchenko V, et al
    Identifying and Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Among At-Risk Veterans.
    Am J Gastroenterol. 2025;120:2559-2566.
    >> Share

    October 2025
  24. DE FARIA MORAES B, Pedral Diniz Leite GA, Pedral Diniz Leite GA, Motta Fonseca ML, et al
    Reevaluating the Role of Proton Pump Inhibitors After Endoscopic Band Ligation of Esophageal Varices in Cirrhotic Patients: A Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2025 Oct 21. doi: 10.14309/ajg.0000000000003800.
    >> Share

  25. CHIRAPONGSATHORN S, Chang A, Malikhao S, Wanichagool D, et al
    One versus five days of octreotide infusion for acute esophageal variceal bleeding: a randomized controlled trial.
    Am J Gastroenterol. 2025 Oct 15. doi: 10.14309/ajg.0000000000003791.
    >> Share

  26. ZHANG X, Ning C, Yang X
    The Illusion of Response: Diffuse Hepatic Metastasis Masked by Shrinking Lesions in Neuroendocrine Carcinoma of the Cervix.
    Am J Gastroenterol. 2025 Oct 10. doi: 10.14309/ajg.0000000000003788.
    >> Share

  27. BOIKE JR, Gallegos-Orozco JF, Duarte-Rojo A
    Rallentando un Poco : Carvedilol and Its Role in Cirrhosis Progression.
    Am J Gastroenterol. 2025 Oct 3. doi: 10.14309/ajg.0000000000003765.
    >> Share

  28. KHAN Z
    Continuing Medical Education Questions: October 2025.
    Am J Gastroenterol. 2025;120:2236.
    >> Share

  29. RATTAN P, Ahn JC, Chara BS, Mullan AF, et al
    Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2025;120:2452-2456.
    >> Share

  30. LEE HH, Lee HA, Kim EJ, Kim HY, et al
    Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study.
    Am J Gastroenterol. 2025;120:2321-2329.
    >> Share

  31. WU C, Targher G, Byrne CD, Mao Y, et al
    Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021.
    Am J Gastroenterol. 2025;120:2280-2290.
    >> Share

  32. KIM WR, Mannalithara A, Charu V, Chung N, et al
    Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2025;120:2312-2320.
    >> Share

  33. LUTZ MK, Caldera F
    Vaccination Outcomes and Recommendations Among Older Adults in a Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2025;120.
    >> Share

  34. BROWN CL, Bajaj JS
    Considerations in the Diagnoses and Management of Hepatic Disease in Older Adults.
    Am J Gastroenterol. 2025;120.
    >> Share

    September 2025
  35. PATEL AA, O'Leary JG, Bajaj JS, Prause N, et al
    Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003781.
    >> Share

  36. HASJIM BJ, Patel M, Chen S, Ichii H, et al
    Social Determinants of Health and Liver Transplant Outcomes in U.S. Indigenous Populations.
    Am J Gastroenterol. 2025 Sep 26. doi: 10.14309/ajg.0000000000003770.
    >> Share

  37. MAHMUD N, Fricker ZP, McElroy LM, Qayed E, et al
    ACG Clinical Guideline: Perioperative Risk Assessment and Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2025;120:1968-1984.
    >> Share

  38. NIU C, Sun K, Zhang J, Elkhapery A, et al
    Gastrointestinal and Hepatobiliary Safety of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.
    Am J Gastroenterol. 2025 Sep 3. doi: 10.14309/ajg.0000000000003760.
    >> Share

    August 2025
  39. JEFFREY AW, Majumdar A, Jeffrey G, Calzadilla-Bertot L, et al
    The Portal Hypertension Decompensation Score - A Validated Predictive Model of Liver Decompensation Related to Portal Hypertension.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003744.
    >> Share

  40. PRAKASH JH, Anirvan P, Gupta S, Chouhan MI, et al
    Diagnostic Accuracy of Spleen-dedicated 100 Hz Transient Elastography to Predict High-risk Esophageal Varices.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003741.
    >> Share

    July 2025
  41. RANA R, Tabish M, Agarwal S, Bayye R, et al
    Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.
    Am J Gastroenterol. 2025 Jul 31. doi: 10.14309/ajg.0000000000003689.
    >> Share

  42. OUYANG MM G, Chen Mm X, Yao Mm X, Mo Mm X, et al
    Unprecedented Duodenal Erosion of a Transjugular Intrahepatic Portosystemic Shunt Stent: A Rare Trigger for Recurrent Polymicrobial Sepsis.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003680.
    >> Share

  43. NGUYEN NV, Sandstrom A, Dominicus A, Mageau A, et al
    Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies.
    Am J Gastroenterol. 2025 Jul 23. doi: 10.14309/ajg.0000000000003652.
    >> Share

  44. KHAJURIA R, Jindal A, Sharma MK, Arora V, et al
    Efficacy and safety of carvedilol in cirrhosis patients with new-onset uncomplicated ascites without high-risk esophageal varices. (CARVE-AS Trial).
    Am J Gastroenterol. 2025 Jul 21. doi: 10.14309/ajg.0000000000003650.
    >> Share

  45. WOLTSCHE J, Pacher-Deutsch C, Furst S, Gulden L, et al
    Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003634.
    >> Share

  46. ZHANG K, Zhang L, Zhang J, Lu X, et al
    Unexpected Origin: Gastric Mature Cystic Teratoma Presenting as a Hepatic Mass.
    Am J Gastroenterol. 2025 Jul 2. doi: 10.14309/ajg.0000000000003621.
    >> Share

    June 2025
  47. CHAPMAN B, Sinclair M, Majumdar A, Yu C, et al
    Real-world experience of home continuous terlipressin infusion for complications of portal hypertension.
    Am J Gastroenterol. 2025 Jun 11. doi: 10.14309/ajg.0000000000003589.
    >> Share

  48. PEREZ-DIAZ-DEL-CAMPO N, Castelnuovo G, Ferro A, Caviglia GP, et al
    Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Cohor
    Am J Gastroenterol. 2025;120:1779-1790.
    >> Share

  49. SOGBE M, Wong R, Bloomer PM, Steinberg A, et al
    Psychomotor speed from minimal hepatic encephalopathy testing is associated with physical frailty in patients with advanced chronic liver disease.
    Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003583.
    >> Share

    May 2025
  50. DESAI AP, Scherer AN, Serper M
    The Role of Patient-Reported Outcomes in Cirrhosis.
    Am J Gastroenterol. 2025 May 20. doi: 10.14309/ajg.0000000000003551.
    >> Share

  51. HWANG SY, Rezaee-Zavareh MS, Attia AM, Kaymen EA, et al
    Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2025 May 16. doi: 10.14309/ajg.0000000000003546.
    >> Share

  52. SOUZA M, Al-Sharif L, Diaz I, Khalil SM, et al
    Enrollment in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Pooled Analysis of Screen Failure Rates.
    Am J Gastroenterol. 2025 May 5. doi: 10.14309/ajg.0000000000003520.
    >> Share

  53. SINGAL AK, Wong RJ, Dasarathy S, Abdelmalek MF, et al
    ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
    Am J Gastroenterol. 2025;120:950-972.
    >> Share

  54. THOMAS A
    Continuing Medical Education Questions: May 2025.
    Am J Gastroenterol. 2025;120:948.
    >> Share

    April 2025
  55. WALKER T, Alejandro-Soto A, Nephew L, Jones P, et al
    Association of Social Isolation From Living Alone and Psychological Distress Among Adults With Chronic Liver Disease in the United States.
    Am J Gastroenterol. 2025;120:1860-1864.
    >> Share

  56. SINGAL AG, Yang JD, Jalal PK, Salgia R, et al
    Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study.
    Am J Gastroenterol. 2025;120:1800-1808.
    >> Share

  57. MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al
    Rural-urban disparities in hepatocellular carcinoma deaths are driven by hepatitis C-related HCC.
    Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487.
    >> Share

  58. KUMAR A, Arora A, Choudhury A, Arora V, et al
    Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2025;120:816-826.
    >> Share

    March 2025
  59. GARRIDO-TREVINO L, Ahn S, Tapper EB, Walker OC, et al
    Diagnosis of Acute on Chronic Liver Failure in critically ill patients with cirrhosis using administrative data.
    Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003422.
    >> Share

    February 2025
  60. CHOLANKERIL G, Taylor T, Kramer JR, Liu Y, et al
    Inequalities in developing cirrhosis complications over time: A cohort study.
    Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003354.
    >> Share

  61. YUN B, Park H, Ahn SH, Oh J, et al
    Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.
    Am J Gastroenterol. 2025;120:410-419.
    >> Share

    January 2025
  62. DECHARATANACHART P, Poovorawan K, Tangkijvanich P, Charatcharoenwitthaya P, et al
    Cost-Utility Analysis of Non-Invasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003332.
    >> Share

  63. ROMAIN D, Hao S, Grzyb K, Bashaw L, et al
    Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: a prospective evaluation.
    Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003334.
    >> Share

  64. GHANDOUR B, Kaplan DE, Mahmud N
    High Cirrhosis Surgical Volume Centers have Reduced Postoperative Mortality in Patients with Cirrhosis Undergoing Major Surgery.
    Am J Gastroenterol. 2025 Jan 21. doi: 10.14309/ajg.0000000000003329.
    >> Share

  65. MORITA M, Takita M, Nishida N, Kudo M, et al
    Giant Sister Mary Joseph;s nodule in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2025 Jan 17. doi: 10.14309/ajg.0000000000003325.
    >> Share

  66. SILVEY S, Patel N, O'Leary JG, Bajaj JS, et al
    ENHANCEMENT OF CIRRHOSIS MORTALITY PREDICTION BY INCLUDING HEPATIC ENCEPHALOPATHY TO MELD3.0 IN A NATIONAL VETERAN COHORT.
    Am J Gastroenterol. 2025 Jan 16. doi: 10.14309/ajg.0000000000003317.
    >> Share

  67. BERAN A, Elfert K, Patel FN, Mohamed M, et al
    Risk of Post-polypectomy Bleeding After Colorectal Endoscopic Mucosal Resection in Patients With Cirrhosis: A Propensity-Matched Analysis of the US Collaborative Network.
    Am J Gastroenterol. 2025 Jan 16. doi: 10.14309/ajg.0000000000003322.
    >> Share

  68. WONG F, Vagas HE, Reddy KR, Pagadala MR, et al
    The Effects of alfapump on Ascites Control and Quality of Life in Patients with Cirrhosis and Recurrent or Refractory Ascites.
    Am J Gastroenterol. 2025 Jan 6. doi: 10.14309/ajg.0000000000003300.
    >> Share

    December 2024
  69. QIAO Y, Yang L, Yang H, Zheng M, et al
    Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children.
    Am J Gastroenterol. 2024;120:1395-1399.
    >> Share

  70. SINGAL AK, Pannerselvam D, Arab JP, Im G, et al
    Delisting From Liver Transplant List for Improvement and Re-compensation Among Decompensated Patients at one-year.
    Am J Gastroenterol. 2024 Dec 23. doi: 10.14309/ajg.0000000000003259.
    >> Share

  71. MALIK S, Frey LJ, Gutman J, Mushtaq A, et al
    Evaluating Artificial Intelligence-Driven Responses to Acute Liver Failure Queries: A Comparative Analysis Across Accuracy, Clarity, and Relevance.
    Am J Gastroenterol. 2024;120:2081-2085.
    >> Share

  72. LEDENKO M, Patel T
    Poverty Traps and Mortality From Liver Diseases in the United States.
    Am J Gastroenterol. 2024;119:2462-2470.
    >> Share

    November 2024
  73. WONG F, Reddy KR, Tandon P, Lai JC, et al
    Sex differences in patient-reported outcomes and perception of ascites burden amongst outpatients with decompensated cirrhosis and ascites.: Sex Differences in Ascites Burden Perception.
    Am J Gastroenterol. 2024 Nov 27. doi: 10.14309/ajg.0000000000003251.
    >> Share

  74. PACHISIA AV, Agarwal A, Mehta S, Kumari A, et al
    Celiac Disease Is Common in Adults With Cryptogenic Cirrhosis and Responds Favorably to Gluten-Free Diet.
    Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003244.
    >> Share

  75. SHAH N, Sanyal AJ
    A PRAGMATIC MANAGEMENT APPROACH FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOSIS AND STEATOHEPATITIS.
    Am J Gastroenterol. 2024 Nov 21. doi: 10.14309/ajg.0000000000003215.
    >> Share

  76. NIE C, Vaska M, Wong JK, Bathe OF, et al
    Tumor Seeding With Needle Biopsy of Hepatocellular Carcinoma: A Systematic Review.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003210.
    >> Share

  77. LAURENZANO J, Ganesan P, Harrington C, Slaughter JC, et al
    Post-Transjugular Intrahepatic Portosystemic Shunt Right Atrial Pressure and Left Atrial Volume Index Predict Heart Failure and Mortality: Dual Center Experience.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003211.
    >> Share

  78. HUANG Y, Huang H, Wei T, Zhang A, et al
    Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.
    Am J Gastroenterol. 2024;120:1367-1380.
    >> Share

  79. SERPER M, Pulaski ME, Zhang S, Taddei TH, et al
    Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities, and Outcomes.
    Am J Gastroenterol. 2024;120:2059-2071.
    >> Share

  80. BATHEJA MA
    Continuing Medical Education Questions: November 2024.
    Am J Gastroenterol. 2024;119:2172.
    >> Share

  81. SINGAL AG, Parikh ND, Shetty K, Han SH, et al
    Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study.
    Am J Gastroenterol. 2024;119:2251-2258.
    >> Share

    October 2024
  82. BHUSHAN S, Sohal A, Kowdley KV, Agaf FF, et al
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape.
    Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003174.
    >> Share

  83. MURNANE PM, Afshar M, Chamie G, Cook RL, et al
    Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.
    Am J Gastroenterol. 2024;120:1567-1575.
    >> Share

  84. CHEN VL, Oliveri A, Raut C, Chen Y, et al
    TM6SF2-rs58542926 genotype has opposing effects on incidence of hepatic and cardiac events in a community cohort: TM6SF2 effects on liver and cardiac outcomes.
    Am J Gastroenterol. 2024 Oct 30. doi: 10.14309/ajg.0000000000003169.
    >> Share

  85. HASJIM BJ, Harris A, Balbale SN, Obayemi JE, et al
    Social Disadvantage and Disparities in Chronic Liver Disease: A Systematic Review.
    Am J Gastroenterol. 2024;120:1548-1566.
    >> Share

  86. KIM NJ, Vutien P, Borgerding JA, Beste LA, et al
    Hepatic steatosis estimated by VCTE-derived CAP scores was associated with lower risks of liver-related events and all-cause mortality in patients with chronic liver disease.
    Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003161.
    >> Share

  87. UFERE NN, Zeng C, Donlan J, Shalev D, et al
    Psychological Distress is Prevalent and Interdependent Among Patients with Decompensated Cirrhosis and Their Caregivers.
    Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003158.
    >> Share

  88. MOON AM
    Raising the Bar: Is Hepatocellular Carcinoma Surveillance Warranted for Patients With Alcohol-Associated Cirrhosis?
    Am J Gastroenterol. 2024 Oct 24. doi: 10.14309/ajg.0000000000003123.
    >> Share

  89. BARRITT AS 4TH, Hayashi PH, Stolz AA, Barnhart H, et al
    Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.
    Am J Gastroenterol. 2024;120:1307-1313.
    >> Share

  90. CIRICILLO J, Myer A, Yeboah-Korang A, Osman A, et al
    Improving the Diagnostic Accuracy of RECAM in North American Patients With Suspected Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2024;120:1325-1333.
    >> Share

  91. JM E, E V, Nm I
    Predicting and preventing bleeding in patients with cirrhosis undergoing procedures.
    Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003129.
    >> Share

  92. VERMA N, Roy A, Valsan A, Garg P, et al
    Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multi-Centric Study.
    Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003115.
    >> Share

  93. LANZ-ZUBIRIA L, Chavez-Tapia NC
    To Continue or Discontinue beta-Blockers in Secondary Prophylaxis? That is the Dilemma.
    Am J Gastroenterol. 2024;119:2143.
    >> Share

  94. TANAKA T, Vander Weg M, Jones MP, Wehby G, et al
    Assessment of the 2021 AASLD Practice Guidance for Albumin Infusion in Elective Therapeutic Paracentesis: A Regression Discontinuity Design.
    Am J Gastroenterol. 2024;119:2045-2051.
    >> Share

  95. ZAVER HB, Rajpal N, Shah NL, Argo CK, et al
    MELD and MELD 3.0: What It Means for Your Practice.
    Am J Gastroenterol. 2024;119:1951-1954.
    >> Share

    September 2024
  96. JUTRAS G, Flemming JA
    Global Epidemiology of Cirrhosis in Women.
    Am J Gastroenterol. 2024 Sep 19. doi: 10.14309/ajg.0000000000003086.
    >> Share

  97. JENSEN MD, West PJ, Crooks C, Morling JR, et al
    Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies.
    Am J Gastroenterol. 2024 Sep 9. doi: 10.14309/ajg.0000000000003077.
    >> Share

  98. SILVEY S, Patel NR, Tsai SY, Nadeem M, et al
    Higher Rate of SBP Recurrence with Secondary SBP Prophylaxis Compared to No Prophylaxis in Two National Cirrhosis Cohorts.
    Am J Gastroenterol. 2024 Sep 4. doi: 10.14309/ajg.0000000000003075.
    >> Share

  99. WONG RJ, Yang Z, Yeoh A, Do A, et al
    Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2024;119:1841-1848.
    >> Share

    August 2024
  100. KRONSTEN VT, Shawcross DL
    Clinical implications of inflammation in patients with cirrhosis.
    Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003056.
    >> Share

  101. KOWDLEY KV, Hirschfield GM, Coombs C, Malecha ES, et al
    COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
    Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003029.
    >> Share

  102. LI M, Shu W, Zou Y, Xiao H, et al
    Reversing Metabolic Dysfunction-Associated Steatotic Liver Disease Promotes Healthy Pediatric Cardiovascular Structures: The PROC Study.
    Am J Gastroenterol. 2024;119:1640-1643.
    >> Share

  103. BARRITT AS 4TH, Yu F, Mospan AR, Newsome PN, et al
    High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
    Am J Gastroenterol. 2024;119:1624-1627.
    >> Share

  104. VANDERSCHUEREN E, Armandi A, Kwanten W, Cassiman D, et al
    Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2024;119:1515-1524.
    >> Share

  105. STERLING RK, Vilar-Gomez E, Wilson LA, Loomba R, et al
    Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease.
    Am J Gastroenterol. 2024;119:1483-1495.
    >> Share

  106. FONTANA RJ, Li YJ, Vuppalanchi R, Kleiner DE, et al
    ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study.
    Am J Gastroenterol. 2024;119:1496-1505.
    >> Share

  107. LIU C, Cao Z, Yan H, Wong YJ, et al
    Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
    Am J Gastroenterol. 2024;119:1706.
    >> Share

    July 2024
  108. WANG RX, Serper M, Taddei TH, Kaplan DE, et al
    The Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002976.
    >> Share

  109. SHENOY A, Valicevic AN, Lin A, Su GL, et al
    Delivery of Outpatient Cirrhosis Care Via Tele-visit is Not Associated with Increased Mortality as Compared to Traditional In-Person Visits.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002979.
    >> Share

  110. TAPPER EB, Goldberg D, Parikh ND, Terrault NA, et al
    The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
    Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953.
    >> Share

  111. KAZUMORI H, Saima A, Ohno Y
    Development of Giant Hepatocellular Carcinoma Leads to Biliary Plastic Stent Compression Resulting in Pseudoaneurysm Rupture in Right Hepatic Artery.
    Am J Gastroenterol. 2024 Jul 8. doi: 10.14309/ajg.0000000000002938.
    >> Share

  112. ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al
    Improvement in survival after transplantation for critically ill patients with cirrhosis in the United States.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944.
    >> Share

  113. LOUISSAINT J, Kyalwazi B, Deng J, Melendez-Torres J, et al
    Patients With Cirrhosis Rapidly Review Potentially Abnormal Hepatocellular Carcinoma Surveillance Results Through the Patient Portal.
    Am J Gastroenterol. 2024 Jul 3. doi: 10.14309/ajg.0000000000002940.
    >> Share

  114. FRENETTE C, Mendiratta-Lala M, Salgia R, Wong RJ, et al
    ACG Clinical Guideline: Focal Liver Lesions.
    Am J Gastroenterol. 2024;119:1235-1271.
    >> Share

  115. ASKGAARD G, Jepsen P, Jensen MD, Kann AE, et al
    Population-Based Study of Alcohol-Related Liver Disease in England in 2001-2018: Influence of Socioeconomic Position.
    Am J Gastroenterol. 2024;119:1337-1345.
    >> Share

    June 2024
  116. HUANG SC, Su TH, Tseng TC, Liao SH, et al
    Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
    Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915.
    >> Share

  117. BERAN A, Mohamed MFH, Vargas A, Aboursheid T, et al
    Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients with Cirrhosis and Ascites: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002906.
    >> Share

  118. ELHENCE H, Dodge JL, Kahn JA, Lee BP, et al
    Characteristics and Outcomes Among U.S. Commercially Insured Transgender Adults with Cirrhosis: A National Cohort Study.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002907.
    >> Share

  119. PARVATANENI S, Sarkis Y, Haugh M, Baker B, et al
    A comprehensive evaluation of emergency department utilization by patients with cirrhosis.
    Am J Gastroenterol. 2024 Jun 24. doi: 10.14309/ajg.0000000000002905.
    >> Share

  120. THABUT D, Rudler M, Weiss N
    Diagnosis of Overt Hepatic Encephalopathy With a New Algorithm: Follow-up Data Are Required.
    Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002856.
    >> Share

  121. PAIK JM, Duong S, Zelber-Sagi S, Lazarus JV, et al
    Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
    Am J Gastroenterol. 2024;119:1089-1101.
    >> Share

    May 2024
  122. DANPANICHKUL P, Ng CH, Muthiah M, Suparan K, et al
    From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
    Am J Gastroenterol. 2024;119:893-909.
    >> Share

    April 2024
  123. BAJAJ JS, Pimentel M
    Is Hepatic Encephalopathy the First True Disorder of Gut-Brain interaction?
    Am J Gastroenterol. 2024 Apr 22. doi: 10.14309/ajg.0000000000002824.
    >> Share

  124. HUME SJ, Holmes JA, Thompson AJ
    Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
    Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
    >> Share

  125. ERMINELLI D, Mangini C, Zarantonello L, Angeli P, et al
    Overt hepatic encephalopathy - more than meets the eye.
    Am J Gastroenterol. 2024 Apr 8. doi: 10.14309/ajg.0000000000002795.
    >> Share

  126. KHANNA S, Shah NL, Argo CK
    Use of Phosphatidylethanol Testing in Patients With Liver Disease.
    Am J Gastroenterol. 2024;119:596-599.
    >> Share

  127. PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
    Practical Considerations to Optimize Care for Patients With Alcohol-Associated Liver Disease in General Gastroenterology Practice.
    Am J Gastroenterol. 2024;119:591-595.
    >> Share

    March 2024
  128. CHEN YT, Chen TI, Yang TH, Yin SC, et al
    Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002778.
    >> Share

  129. CHEN QF, Chen S, Yi JZ, Wang JL, et al
    Recommended Ten Years' Follow-Up Strategy for Small Hepatocellular Carcinoma after Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002774.
    >> Share

  130. LO GH, Yeh JH, Tseng CH, Chen TH, et al
    A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002776.
    >> Share

  131. TABISH M, Agarwal S, Gopi S, Rana R, et al
    Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
    Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
    >> Share

  132. SAMALA N, Xin Y, Wilson LA, Yates K, et al
    Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002756.
    >> Share

  133. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
    Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
    >> Share

  134. ZHANG X, Daniel CR, Soltero V, Vargas X, et al
    A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
    Am J Gastroenterol. 2024;119:505-511.
    >> Share

    February 2024
  135. SASAKI S, Schmidt S, Uldry E, Halkic N, et al
    Hepaticocholecystic Duct: Not a Myth but a Pitfall in Cholecystectomy.
    Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002725.
    >> Share

  136. LOUISSAINT J, Vargas HE
    Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002659.
    >> Share

  137. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    >> Share

  138. RANGRAY R
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:248.
    >> Share

  139. BATHEJA MA
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:247.
    >> Share

  140. MURPHY CC, Tavakkoli A, Wani S, Singal AG, et al
    Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
    Am J Gastroenterol. 2024;119:382-387.
    >> Share

  141. JULIEN J, Ayer T, Tapper EB, Chhatwal J, et al
    The Rising Costs of Alcohol-Associated Liver Disease in the United States.
    Am J Gastroenterol. 2024;119:270-277.
    >> Share

    January 2024
  142. GE J, Chen IY, Pletcher MJ, Lai JC, et al
    How I Approach It: Prompt Engineering for Generative Artificial Intelligence (GAI) in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002689.
    >> Share

  143. CHARA BS, Hara KS, Penrice D, Schmidt KA, et al
    ARTIFICIAL INTELLIGENCE-ENABLED STOOL ANALYSIS FOR LACTULOSE TITRATION ASSISTANCE IN HEPATIC ENCEPHALOPATHY VIA A SMARTPHONE APPLICATION.
    Am J Gastroenterol. 2024 Jan 19. doi: 10.14309/ajg.0000000000002656.
    >> Share

  144. BLOOM PP, Bajaj JS
    The Current and Future State of Microbiome Therapeutics in Liver Disease.
    Am J Gastroenterol. 2024;119.
    >> Share

  145. KARNA R
    Continuing Medical Education Questions: January 2024.
    Am J Gastroenterol. 2024;119:27.
    >> Share

  146. NICOLETTI P, Dellinger A, Li YJ, Barnhart H, et al
    HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
    Am J Gastroenterol. 2024;119:200-202.
    >> Share

    December 2023
  147. FAGAN A, Gallagher ML, Mousel T, Davis BC, et al
    AI evaluation of Stool Quality Guides Management of Hepatic Encephalopathy using a Smartphone App.
    Am J Gastroenterol. 2023 Dec 28. doi: 10.14309/ajg.0000000000002646.
    >> Share

  148. MUI BG, Grinspan LT, Crismale JF
    Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002640.
    >> Share

  149. MULGAONKAR A, Huang DQ, Siddiqi H, Fowler K, et al
    Cost-Effectiveness Analysis of HCC Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis using US Visualization Score C-Triggered Abbreviated MRI.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002636.
    >> Share

  150. PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
    High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
    >> Share

  151. LEE JD, Gounko D, Lee JA, Mukherjee T, et al
    Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease.
    Am J Gastroenterol. 2023;118:2184-2190.
    >> Share

    November 2023
  152. DAHER D, El Dahan KS, Yekkaluri S, Gopal P, et al
    Proportion Time Covered by Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002596.
    >> Share

  153. HASHMI I, Chadha N, McIntosh G, Sterling R, et al
    Quality Improvement for Health Care Providers in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002609.
    >> Share

  154. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
    Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
    Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
    >> Share

  155. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
    Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
    >> Share

  156. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
    Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
    >> Share

  157. WANG B, Zhou J, Wu X, Sun Y, et al
    Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
    Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
    >> Share

  158. YAGHOOBI M
    Continuing Medical Education Questions: November 2023.
    Am J Gastroenterol. 2023;118:1925.
    >> Share

  159. KIM J, Zhang Y, Kim H, Zhang Y, et al
    A Comparative Study of Healthy Dietary Patterns for Incident and Fatal Digestive System Cancer.
    Am J Gastroenterol. 2023;118:2061-2070.
    >> Share

  160. SQUIZZATO F, Abruzzino G, Piazza M
    Acute Liver Failure in a Patient With Previous Vascular Surgery for Bowel Ischemia.
    Am J Gastroenterol. 2023;118:1919.
    >> Share

  161. CHO Y, Chang Y, Ryu S, Kim C, et al
    History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study.
    Am J Gastroenterol. 2023;118:1980-1988.
    >> Share

    October 2023
  162. LV XH, Lu Q, Deng K, Yang JL, et al
    Prevalence and characteristics of covert/minimal hepatic encephalopathy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Am J Gastroenterol. 2023 Oct 19. doi: 10.14309/ajg.0000000000002563.
    >> Share

  163. SILKE L, Donata G, Dominik G, Uli F, et al
    Endoscopic features of post-COVID-19 cholangiopathy and its management using ERCP.
    Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
    >> Share

  164. OZTURK NB, Jamil LH, Tapper EB
    Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002560.
    >> Share

  165. PRASOPPOKAKORN T, Panarat P
    Disseminated Melioidosis infection involving hepatosplenomegaly and massive extramedullary hematopoiesis.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002549.
    >> Share

  166. PULASKI M, Bittermann T, Taddei TH, Kaplan DE, et al
    The Association between Homelessness and Key Liver-Related Outcomes in Veterans with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 2. doi: 10.14309/ajg.0000000000002535.
    >> Share

  167. ONG J, Mandour MO, Allison M
    Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1899.
    >> Share

    September 2023
  168. NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al
    Osteoporosis and fragility fractures in patients with cirrhosis evaluated for liver transplantation: Identification of high-risk patients based on computed tomography at evaluation.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507.
    >> Share

  169. FENG X, Li H, Bajaj J, Moon AM, et al
    Endoscopic Ultrasound (EUS)-guided Sclerotherapy with Lauromacrogol: A Novel Therapy for A Giant Esophageal Hemangioma.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002514.
    >> Share

    July 2023
  170. LARINO-NOIA J, Fernandez-Castroagudin J, de la Iglesia-Garcia D, Lazare H, et al
    Quality of Tissue Samples Obtained by Endoscopic Ultrasound-Guided Liver Biopsy: A Randomized, Controlled Clinical Trial.
    Am J Gastroenterol. 2023 Jul 14. doi: 10.14309/ajg.0000000000002375.
    >> Share

    March 2023
  171. LIU Y, Guo G, Zheng L, Sun R, et al
    Effectiveness of fenofibrate in treatment-naive patients with primary biliary cholangitis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002238.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016